mTOR inhibitors are a class of drugs that specifically target the mammalian target of rapamycin (mTOR), a critical kinase involved in cell growth, proliferation, and survival. mTOR forms part of the larger mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). These complexes regulate various cellular processes, making them significant in the context of cancer treatment.
